Canal-U

Mon compte

Résultats de recherche

Nombre de programmes trouvés : 541
Label UNT Conférences

le (52m28s)

JRM2014 Actualités sur la prise en charge du cancer de la prostate

Actualités sur la prise en charge du cancer de la prostate. Pr A. Villers, Dr Ph. Puech, Dr D. Pasquier, Dr R. Crestel, Dr JM. Blondel.La JRM - Journée Régionale de Médecine est un congrés annuel de Formation Médicale Continue en médecine générale de la région Nord-Pas de Calais, organisée par la Faculté de Médecine de Lille en partenariat avec l'URPS médecins libéraux et NORFORMED. Vous pouvez y découvrir diverses communications, ateliers, petits déjeuners ... en lien avec la médecine générale.Les sessions sont toujours animées par un spécialiste et un médecin généraliste.Congrés JRM
Voir la vidéo
Conférences

le (1h29m32s)

Forum Santé Margo Initiative: Cancer et environnement : des liaisons dangereuses

Titre : Forum Santé Margo Initiative: Cancer et environnement : des liaisons dangereusesIntervenants : Pr Weryha chef du service d’endocrinologie CHU Nancy et le Dr Elisabeth Luporsi, oncologue à l’ICL.Résumé : Il est temps de faire le point. Quels liens existe t -il entre notre environnement et le développement des cancers ? Le public s’interroge. Des questions scientifiques se posent sur le rôle de facteurs environnementaux, professionnels et comportementaux. De quels éléments disposons-nous pour le savoir ? La recherche est très active dans ce domaine. Même si le ...
Voir la vidéo
Entretiens

le (1h22m44s)

Forum Santé Margo Initiative: Cancer... Quoi de neuf?

Titre : Forum Santé Margo Initiative: Cancer... Quoi de neuf?Date : 16/10/2014Horaires : 17h30Lieu : Cinéma Le Palace MetzIntervenants : Le Docteur Quetin, responsable du service de radiothérapie du CHR Metz- Thionville, le Docteur Dehayes de l'Amodemaces et Francis Flamain de la ligue contre le cancer 57 répondront aux questions du public. Résumé : La fondation Arc pour la recherche contre le cancer , annonce « Guérir 2 cancers sur 3 nous on y croit... ». A quelle échéance raisonnable peut-on l'envisager? Que savons-nous aujourd'hui que ...
Voir la vidéo
Conférences

le (13m2s)

BRIO's facts and figures, structuration projects : Axe Cancer, translational research centerUpdate the implementation of BRIO

Update the implementation of BRIO Brio organisation is now fully up and running, and more than 100 research projects are currently active into the 6 integrated research programmes. In addition, major progresses were achieved at the level of the 7 strategic axes defined to structure and support cancer research in Bordeaux. The bioinformatics axis saw the recruitment of 4 bioinformaticians (2 funded by BRIO) and the creation of a transversal bioinformatics axis at the University. For the in-vivo research axis, a project to develop a translational research center is currently being developed ...
Voir la vidéo
Conférences

le (22m11s)

Technique, research and benefits

Interface technology/clinical/SHS/public health : case study interventional radiology  >> Jean PalussièreRadiology in oncology or so called interventional oncology is now considered by certain as the fourth oncological discipline, alongside surgical, radiation, and medical oncology. This makes it particularly dynamic and it is important for interventional radiologists to stay on top of technological developments. During the last ten years the therapeutic part of Interventional Oncology has rapidly grown in different fields such as thermal ablation and local drug delivery. Thermal ablation, which allows to treat tumors with temperature modifications, has known an increasing development during the last 10 years ...
Voir la vidéo
Conférences

le (18m29s)

Sociology contribution to understanding the (no)diffusion of a medical innovation

Interface technology/clinical/SHS/public health : case study interventional radiology We will present results of an undergoing study on the socioeconomic processes of recognition in oncology of a long-standing medical innovation, the so-called interventional radiology (IR). This project is conducted by a multidisciplinary team gathering health sociologist, sociologist of science, economist of innovation, health lawyer and interventional radiologist, supported by INCa. With scientometrics and patent landscaping, we get an understanding of the IR discoveries’ chronology and identify the relationships established between science, medicine and industry. Through field observations and semi-directed interviews, we analyzed the strategies of legitimation of IR, seeking ...
Voir la vidéo
Conférences

le (19m21s)

Cost-effectiveness analysis for decision making, illustrated theory

Interface technology/clinical/SHS/public health : case study interventional radiologyIn a health care system with limited resources, each euro invested in a health care intervention is no longer available for another intervention. This imposes the need for a prioritization of health care interventions according to their additional value for money for maximizing health at a given cost. Cost-effectiveness analyses may answer two main questions: 1) does an intervention present sufficient value for money to be funded within a health system? The decision is based on the absolute value of the incremental cost-effectiveness ratio; 2) is further research needed to inform the decision ...
Voir la vidéo
Conférences

le (9m11s)

Innovation reimbursement

Interface technology/clinical/SHS/public health : case study interventional radiology Novel diagnostic and therapeutic strategies is a continuum of 3 strongly associated phases : clinical research, medico-economic evaluation of a novel strategy and deployment of innovation, the last one being a field of competence of centers of expertise such as SIRIC BRIO.In the full cycle of innovation, the money time is the major challenge of a large deployment. The main problem is to find money. But, in 2015, 3 changes should improve the innovation continuum. Should it be a progress, an obstacle, or both ?...Cette présentation a été donnée dans ...
Voir la vidéo
Conférences

le (15m1s)

Standardizing G8 evaluation

Non-pharmaceutical innovations and public healthManagement of the frail elderly with cancer is a challenge. Beside a poor outcome as compared to younger subjects, physicians will face increased risk of treatment-induced toxicity but also unexpected adverse events because of the underlying comorbidities and potential major consequences of these toxicities on the outcome because of frailty. In depth evaluation of the patient through geriatric assessment has been demonstrated as predictive of these adverse events but is time-consuming so that only a minority of cancer treatment hospitals will be able to propose it. Screening is part of the solution and G8 one of ...
Voir la vidéo
Conférences

le (19m53s)

Curing leukemia ?

Non-pharmaceutical medical innovations and public healthThe use of tyrosine kinase inhibitors (TKIs) targeted against the BCR-ABL1 oncoprotein has proven remarkably successful in chronic myeloid leukemia (CML) and long-term survival has become a reality. Despite this outstanding progress, detection of minimal residual disease precludes therapy termination in most TKI-receiving patients. CML has thus turned into a chronic illness, raising concerns about long-term safety, medication adherence and healthcare costs. Although treatment cessation may be feasible in few selected patients achieving deep molecular responses, a definitive cure remains elusive owing to the discovery that TKIs spare quiescent leukemic stem cells (LSC). Understanding mechanisms ...
Voir la vidéo

 
FMSH
 
Facebook Twitter Google+
Mon Compte